| Date | Title | Description |
| 02.05.2017 | Advanced Cardiac Therapeutics Raises $45M |
SANTA CLARA, CA, Advanced Cardiac Therapeutics today announced $45 million in new equity funding.
>> Click here for more funding data on Advanced Cardiac Therapeutics
>> To export Advanced Cardiac Therapeutics funding data t... |
| 02.05.2017 | NEA Joins $45M Funding for Advanced Cardiac Therapeutics | SANTA CLARA, Calif.--(BUSINESS WIRE)--Advanced Cardiac Therapeutics, Inc.,, a medical device company focused on developing a next-generation ablation catheter to treat cardiac arrhythmias including atrial fibrillation, today announced $45 m... |
| 02.05.2017 | Advanced Cardiac Therapeutics Raises $45M in Equity Funding | Advanced Cardiac Therapeutics, Inc., a Santa Clara, Calif.-based medical device company focused on developing a next-generation ablation catheter to treat cardiac arrhythmias including atrial fibrillation, raised $45m in equity funding.
The... |
| 02.05.2017 | Term Sheet — Tuesday, May 2 | PUTTING THE SILICON IN SILICON VALLEY
Today we have another installment in Term Sheet’s series of interviews with dealmakers at the tech industry’s most active acquirers. Cisco is an acquisition machine, having done nearly 200 deals in its ... |
| 21.04.2014 | Advanced Cardiac Therapeutics Completes Equity Financing Round | Advanced Cardiac Therapeutics, Inc., a Santa Clara, CA-based medical device company that is developing a temperature-sensing, irrigated, radiofrequency (RF) ablation catheter for treatment of cardiac arrhythmias, completed a new round of eq... |
| 11.01.2010 |
Advanced Cardiac Therapeutics Raises $5M
| Laguna Beach-based Advanced Cardiac Therapeutics, which develops advanced cardiac ablation systems, said this morning that it has raised $5M in a Series B funding. According to the firm, the funding was led by NBGI Ventures. The firm said t... |
| 11.01.2010 | Advanced Cardiac Therapeutics Completes $5M Series B Equity Financing | Advanced Cardiac Therapeutics, Inc., a Laguna Beach, California-based developer of advanced irrigated cardiac ablation systems, completed a $5m Series B equity financing.
The round was led by NBGI Ventures, a venture capital firm specialize... |
